On March 14, 2022, Raymond Pratt notified Rockwell Medical, Inc. of his decision to resign as the Company's Chief Development Officer, effective as of March 25, 2022.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.74 USD | 0.00% | +9.76% | -4.76% |
May. 14 | Transcript : Rockwell Medical, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
May. 14 | Earnings Flash (RMTI) ROCKWELL MEDICAL Reports Q1 Revenue $22.7M, vs. Street Est of $21.7M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.76% | 51.09M | |
+32.34% | 694B | |
+29.39% | 593B | |
-1.61% | 371B | |
+19.95% | 331B | |
+6.67% | 290B | |
+14.04% | 239B | |
-3.15% | 209B | |
+9.84% | 209B | |
+7.98% | 169B |
- Stock Market
- Equities
- RMTI Stock
- News Rockwell Medical, Inc.
- Raymond Pratt Resigns from Rockwell Medical, Inc. as Chief Development Officer, Effective March 25, 2022